In a recent edition of this journal, Fianchi et al. [1] retrospectively analyzed the outcomes of 31 patients with chronic myelomonocytic leukemia (CMML) treated with the hypomethylating agent azaci...
No takes yet. Share an insight, caveat, or question.
Wong et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: